KELLY KAY BENNETT

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CENTENNIAL, CO NPI 1891184875

General Payments — all program years on this page

$2,757.46

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 138
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $831.32 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $831.3242

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $134.471
2022 $299.8414
2023 $1,491.8381
2024 $831.3242

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086758135 Novartis Pharmaceuticals Corporation $24.79 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092648803 Boston Scientific Corporation $19.93 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101422926 E.R. Squibb & Sons, L.L.C. $18.84 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104281981 AstraZeneca Pharmaceuticals LP $13.41 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104433599 AstraZeneca Pharmaceuticals LP $19.51 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104436693 AstraZeneca Pharmaceuticals LP $19.48 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104448535 AstraZeneca Pharmaceuticals LP $15.06 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105623867 AstraZeneca Pharmaceuticals LP $13.95 01/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105656730 AstraZeneca Pharmaceuticals LP $58.91 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513910 ABBVIE INC. $24.70 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513912 ABBVIE INC. $23.21 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513914 ABBVIE INC. $26.43 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513916 ABBVIE INC. $4.94 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513918 ABBVIE INC. $2.56 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513920 ABBVIE INC. $22.47 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513922 ABBVIE INC. $34.85 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513924 ABBVIE INC. $24.99 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513926 ABBVIE INC. $6.67 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513928 ABBVIE INC. $30.84 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513930 ABBVIE INC. $34.74 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513932 ABBVIE INC. $3.64 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513934 ABBVIE INC. $3.05 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513936 ABBVIE INC. $20.68 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513938 ABBVIE INC. $20.10 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513940 ABBVIE INC. $29.51 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106513942 ABBVIE INC. $20.48 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110809014 Eisai Inc. $17.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116091216 GlaxoSmithKline, LLC. $15.05 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117201722 Amgen Inc. $15.96 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118216873 Boehringer Ingelheim Pharmaceuticals, Inc. $15.73 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125631728 Seqirus USA Inc $26.17 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128752327 SANOFI PASTEUR INC. $16.37 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131440244 PFIZER INC. $25.86 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131440643 PFIZER INC. $22.75 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131493385 PFIZER INC. $13.79 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131527344 PFIZER INC. $25.24 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131567173 PFIZER INC. $16.97 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135771928 Lilly USA, LLC $14.01 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135791056 Lilly USA, LLC $13.79 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135791058 Lilly USA, LLC $15.67 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143374575 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.83 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150009050 Exeltis, USA Inc. $15.91 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.